Invention Grant
- Patent Title: Mammalian cell cryopreservation liquid
-
Application No.: US16468773Application Date: 2017-11-08
-
Publication No.: US11889829B2Publication Date: 2024-02-06
- Inventor: Masuhiro Nishimura , Natsuki Watanabe , Yasutaka Fujita , Tamaki Wada
- Applicant: OTSUKA PHARMACEUTICAL FACTORY, INC.
- Applicant Address: JP Tokushima
- Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.
- Current Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.
- Current Assignee Address: JP Tokushima
- Agency: GREENBLUM & BERNSTEIN, P.L.C.
- Priority: JP 16242200 2016.12.14
- International Application: PCT/JP2017/040272 2017.11.08
- International Announcement: WO2018/110159A 2018.06.21
- Date entered country: 2019-06-12
- Main IPC: A01N1/02
- IPC: A01N1/02 ; C12N5/0775

Abstract:
A liquid for cryopreserving a cell and a liquid for administration of a mammalian cell capable of cryopreserving a mammalian cell and effectively suppressing cell death after thawing, and a method for cryopreserving a mammalian cell using the cell cryopreservation liquid. The liquid is an isotonic solution that includes 2.0 to 6.0% (w/v) of trehalose or a derivative thereof, or a salt of the trehalose or the derivative, 4.0 to 7.0% (w/v) of dextran or a derivative thereof, or a salt of the dextran or the derivative, and DMSO or glycerin.
Public/Granted literature
- US20200077643A1 MAMMALIAN CELL CRYOPRESERVATION LIQUID Public/Granted day:2020-03-12
Information query